EARAX
Price
$15.63
Change
+$0.02 (+0.13%)
Updated
Nov 19 closing price
Net Assets
253.87M
JNBZX
Price
$10.37
Change
-$0.01 (-0.10%)
Updated
Nov 19 closing price
Net Assets
8.39B
Interact to see
Advertisement

EARAX vs JNBZX

Header iconEARAX vs JNBZX Comparison
Open Charts EARAX vs JNBZXBanner chart's image
Eaton Vance All Asset Strategy A
Price$15.63
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets253.87M
JPMorgan Income Builder R6
Price$10.37
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets8.39B
EARAX vs JNBZX Comparison Chart in %
View a ticker or compare two or three
VS
EARAX vs. JNBZX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EARAX is a Hold and JNBZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNBZX has more cash in the bank: 8.39B vs. EARAX (254M). JNBZX pays higher dividends than EARAX: JNBZX (5.64) vs EARAX (1.88). EARAX was incepted earlier than JNBZX: EARAX (14 years) vs JNBZX (8 years). EARAX (1.24) is less costly to investors than JNBZX (0.57). JNBZX is a more actively managed with annual turnover of: 107.00 vs. EARAX (49.00). EARAX has a lower initial minimum investment than JNBZX: EARAX (1000) vs JNBZX (15000000). JNBZX annual gain was more profitable for investors over the last year : 9.95 vs. EARAX (8.26). JNBZX return over 5 years is better than : 20.95 vs. EARAX (6.94).
EARAXJNBZXEARAX / JNBZX
Total Expense Ratio1.130.52217%
Annual Report Gross Expense Ratio1.240.57218%
Fund Existence14 years8 years-
Gain YTD9.23711.03784%
Front Load5%N/A-
Min. Initial Investment1000150000000%
Min. Initial Investment IRAN/AN/A-
Net Assets254M8.39B3%
Annual Yield % from dividends1.885.6433%
Returns for 1 year8.269.9583%
Returns for 3 years23.9931.1677%
Returns for 5 years6.9420.9533%
Returns for 10 years31.31N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTHCX19.790.03
+0.15%
Invesco Health Care C
DCEMX15.25N/A
N/A
Dunham Emerging Markets Stock C
LMPRX98.27N/A
N/A
ClearBridge Growth R
IUAIX32.81N/A
N/A
VY® Invesco Equity and Income I
RPEBX70.03-0.07
-0.10%
American Funds New Perspective R2E